行情

ZTS

ZTS

硕腾
NYSE

实时行情|Nasdaq Last Sale

126.41
-2.06
-1.60%
交易中 14:41 10/14 EDT
开盘
128.83
昨收
128.47
最高
128.95
最低
126.27
成交量
100.39万
成交额
--
52周最高
130.09
52周最低
78.90
市值
603.68亿
市盈率(TTM)
44.81
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ZTS 新闻

  • Zoetis (ZTS) Soars to 52-Week High, Time to Cash Out?
  • Zacks.4小时前
  • Is Zoetis (ZTS) Stock Outpacing Its Medical Peers This Year?
  • Zacks.5小时前
  • Is Zoetis Inc.'s (NYSE:ZTS) High P/E Ratio A Problem For Investors?
  • Simply Wall St..2天前
  • Debra Brede: Stock Opportunities Abound
  • marketwatch.com.3天前

更多

所属板块

制药
+0.09%
制药与医学研究
+0.16%

热门股票

名称
价格
涨跌幅

ZTS 简况

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.
展开

Webull提供Zoetis Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。